Clinical Trial Update: Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of AN2728 (crisaborole) 2% topical ointment in children, adolescents, and adults aged 2 years and older with at…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Eucrisa (crisaborole)

Snippet

Sponsor: Pfizer | Conditions: Dermatitis, Atopic | Phase 3 | Status: COMPLETED | Results posted: 2017-03-06